Holen Sie sich die Stockscreener-App
11.33
2.26%
0.25
Schlusskurs vom Vortag:
$11.08
Offen:
$11.08
24-Stunden-Volumen:
88,067
Relative Volume:
1.06
Marktkapitalisierung:
$69.72M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.4665
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
+14.79%
1M Leistung:
+64.56%
6M Leistung:
+55.21%
1J Leistung:
-63.24%
1-Tages-Spanne:
$10.65
$11.50
1-Wochen-Bereich:
$9.80
$11.50
52-Wochen-Spanne:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
11.33 | 68.18M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
Contrasting Neurogene (NASDAQ:NGNE) & Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Would You Still Hold Aligos Therapeutics Stock If It Fell 30%? - Trefis
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and ANI Pharmaceuticals (NASDAQ:ANIP) - Defense World
Why Aligos Therapeutics Inc. (5WK0) stock could be next leaderWeekly Trend Summary & Safe Capital Growth Plans - Newser
How supply shortages influence Aligos Therapeutics Inc. (5WK0) stockJuly 2025 Gainers & Low Drawdown Investment Strategies - Newser
What dividend safety rating applies to Aligos Therapeutics Inc. (5WK0) stockGold Moves & AI Driven Stock Movement Reports - Newser
Can Aligos Therapeutics Inc. (5WK0) stock sustain margin levelsJuly 2025 Highlights & Verified Entry Point Signals - Newser
What is the fair value estimate for Aligos Therapeutics Inc. (5WK0) stock in 2025Gap Down & Long-Term Capital Growth Strategies - Newser
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Why Aligos Therapeutics Inc. stock is a value investor pickJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Can Aligos Therapeutics Inc. stock beat market expectations this quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Will Aligos Therapeutics Inc. (5WK0) stock split increase liquidityMarket Movers & Free Real-Time Volume Trigger Notifications - Newser
Responsive Playbooks and the ALGS Inflection - news.stocktradersdaily.com
Sio Capital Management LLC Increases Stock Position in Aligos Therapeutics, Inc. $ALGS - MarketBeat
Why analysts upgrade Aligos Therapeutics Inc. stockPortfolio Gains Report & Fast Momentum Entry Tips - BỘ NỘI VỤ
Aligos Therapeutics Stock Rockets 57% With 7-Day Winning Streak - Trefis
Understanding the Setup: (ALGS) and Scalable Risk - news.stocktradersdaily.com
Is Aligos Therapeutics Inc. (5WK0) stock a good hedge against inflationJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Why Aligos Therapeutics Inc. stock could outperform in 2025Market Growth Summary & AI Optimized Trade Strategies - newser.com
Transcript : Aligos Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-17-2025 03 - MarketScreener
Is Aligos Therapeutics Inc. stock undervalued vs historical averagesEntry Point & Entry Point Confirmation Alerts - newser.com
What moving averages say about Aligos Therapeutics Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Will Aligos Therapeutics Inc. (5WK0) stock outperform global peersJuly 2025 Analyst Calls & Short-Term High Return Ideas - newser.com
When is the best time to exit Aligos Therapeutics Inc.July 2025 Earnings & High Win Rate Trade Alerts - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a buy on weaknessOptions Play & Community Driven Trade Alerts - newser.com
What makes Aligos Therapeutics Inc. (5WK0) stock appealing to growth investorsMarket Performance Recap & Technical Confirmation Trade Alerts - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueBull Run & Accurate Trade Setup Notifications - newser.com
Will Aligos Therapeutics Inc. benefit from macro trendsJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock sustain institutional flowsQuarterly Portfolio Report & Smart Investment Allocation Insights - newser.com
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):